Sponsor:
Theratechnologies
Code:
NCT04706962
Conditions
Solid Tumor
TNBC - Triple-Negative Breast Cancer
Hormone Receptor-positive Breast Cancer
Epithelial Ovarian Cancer
Endometrial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TH1902
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Theratechnologies on 2025-04-15.